Author headshot

Namrata Singh, MD, MSCI

Namrata Singh, MD, MSCI, is an adjunct assistant professor in the department of epidemiology and an assistant professor in the department of rheumatology at the University of Washington School of Public Health.

Most recent by Namrata Singh, MD, MSCI

SPONSORED CONTENT
December 10, 2024
3 min watch
Save

VIDEO: Asking ‘clinically meaningful’ questions about RA, cancer

WASHINGTON — In this video, Namrata Singh, MD, MSCI, discusses a presentation from ACR Convergence 2024 that examined patients with rheumatoid arthritis who develop lung cancer.

SPONSORED CONTENT
December 09, 2024
4 min watch
Save

VIDEO: ‘Rising star’-led presentations in rheumatoid arthritis at ACR

WASHINGTON — In this video, Namrata Singh, MD, MSCI, highlights two posters from her team investigating associations between cancer and rheumatoid arthritis, led by “rising stars.”

SPONSORED CONTENT
December 09, 2024
4 min watch
Save

VIDEO: ACR ‘packed with new knowledge’ in rheumatoid arthritis space

WASHINGTON — In this video, Namrata Singh, MD, MSCI, spotlights three important abstracts in rheumatoid arthritis presented at ACR Convergence 2024.

SPONSORED CONTENT
April 22, 2024
3 min read
Save

Notes from the field: irAE consortium ‘organizing’ providers across specialties

Indications for the use of checkpoint inhibitors are ever expanding. However, even as these drugs have helped patients with cancer live longer, the emergence of various immune related adverse events limits their full potential in many.

SPONSORED CONTENT
February 15, 2023
2 min watch
Save

VIDEO: Importance of selecting JAK inhibitors based on individual patient

SPONSORED CONTENT
February 15, 2023
3 min watch
Save

VIDEO: Cardiovascular concerns tied to JAK inhibitor impacts patients, providers

SPONSORED CONTENT
February 15, 2023
1 min watch
Save

VIDEO: JAK inhibitors field is 'continuing to evolve'

SPONSORED CONTENT
February 15, 2023
2 min watch
Save

VIDEO: Interesting data on JAK inhibitors presented at ACR 2022